Positive results in the anticardiolipin antibody (aCL), anti-β 2-glycoprotein I antibody (aβ 2
GPI), and/or lupus anticoagulant (LA) assays constitute the laboratory criteria for the definite …

Current classification criteria for definite antiphospholipid syndrome (APS) mandate the use
of one or more of three positive 'standardized'laboratory assays to detect antiphospholipid …

The measurement of antiphospholipid antibodies (aPL) has been an important aspect of
antiphospholipid syndrome (APS) characterization since the disease was first described in …

The laboratory criteria that define patients with antiphospholipid syndrome (APS) include
lupus anticoagulant (LAC), anticardiolipin antibodies and anti‐β2 glycoprotein I antibodies …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of circulating
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL) …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of circulating
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LAC), anticardiolipin …

Over 30 years since it was first described as a discrete clinical entity, the antiphospholipid
antibody syndrome (APS) remains a challenge for both laboratory workers and clinicians in …

The pathogenic role of antiphospholipid antibodies (aPL) has been widely established over
past years in several experimental models and clinical studies. Accordingly, the detection of …

The laboratory criteria (lupus anticoagulants (LA), and/or anti-cardiolipin (aCL) antibodies
and/or anti-β2-glycoprotein I antibodies (aβ2GPI)) that define patients with antiphospholipid …

According to classification criteria for antiphospholipid syndrome (APS), laboratory
diagnosis is based on the detection of antiphospholipid antibodies (aPL) by immunological …